- TheStreet.com•3 hours ago
GlaxoSmithKline (GSK) appointed Brian McNamara CEO of its consumer healthcare division on Wednesday.
- Bloomberg•5 hours ago
GlaxoSmithKline Plc named Brian McNamara the head of its consumer-health division, replacing Emma Walmsley a week after she was chosen as the next leader of the U.K.’s biggest drugmaker.
- Reuters•5 hours ago
GlaxoSmithKline (GSK.L) has promoted a former Novartis (NOVN.S) executive to lead its consumer healthcare business, following the appointment last week of the unit's previous head, Emma Walmsley, as CEO designate of the drugmaker. The British group said on Thursday that Brian McNamara, 50, who currently heads up Europe and the Americas at GSK Consumer Healthcare, would take on his new role immediately and join GSK's corporate executive team. McNamara worked for 11 years at Novartis, where he was also in charge of consumer health, and joined GSK following the creation of a joint venture between the two companies in 2015.
GlaxoSmithKline plc (GSK)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||42.90 x 1000|
|Ask||42.91 x 900|
|Day's Range||42.86 - 43.67|
|52wk Range||37.82 - 45.58|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||2,683.12|
|Avg Vol (3m)||2,859,723|
|Dividend & Yield||2.20 (5.09%)|